Nurix Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
NRIX on Nasdaq
Location
1700 Owens Street, Suite 205, San Francisco, CA

Insiders trading volume in the past year

Nurix Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures III, L.P. 10%+ Owner $35.1M May 6, 2021
Column Group L P 10%+ Owner $14.4M May 7, 2021
Gwenn Hansen Chief Scientific Officer $1.53M -$247K -13.9% Jul 30, 2025
Christine Ring Chief Legal Officer $1.23M -$902K -42.3% Jul 30, 2025
Pierre Beaurang Chief Business Officer $1.21M Aug 10, 2021
Hans van Houte Chief Financial Officer $1.09M -$493K -31.1% Aug 1, 2025
Stefani Wolff EVP and COO $146K Apr 30, 2023
Julia P. Gregory Director $20K Sep 17, 2025
Lori Anne Kunkel Director $0 May 19, 2025
Anil Kapur Director May 19, 2025
Leon Chen Director May 6, 2021
David L. Lacey Director May 19, 2025
Jeffrey K. Tong Director, 10%+ Owner May 6, 2021
Judith A. Reinsdorf Director May 19, 2025
Arthur T. Sands President, CEO, Director Feb 11, 2025
Edward C. Saltzman Director May 19, 2025
Paul M. Silva Director May 19, 2025
Clay B. Siegall Director May 5, 2022
Roy D. Baynes Director May 19, 2025

Recent Insider Transactions by Companies or Individuals for Nurix Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.